Easy To Use Patents Search & Patent Lawyer Directory
At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.
Searching:
Search by keyword, patent number, inventor, assignee, city or state:
| Patent # | Description |
|---|---|
| US-9,931,412 |
Targeted theranostics Provided herein is technology relating to theranostic agents and particularly, but not exclusively, to compositions comprising cell-specific theranostic agents... |
| US-9,931,411 |
Microparticles containing physiologically active peptide, method for
preparing the same, and pharmaceutical... Disclosed are microparticles containing physiologically active peptides, a method for preparing the same, and a pharmaceutical composition comprising the same. |
| US-9,931,410 |
Nanoparticles for targeted delivery of multiple therapeutic agents and
methods of use Provided herein are compositions that contain a nanoparticle containing a plurality of polymers, wherein at least a fraction of the polymers comprise a... |
| US-9,931,409 |
Methods and materials for therapeutic delivery Method for preparing a supramolecular therapeutic agent delivery assembly are provided. A carbonate-containing precursor, a functionalized aliphatic precursor,... |
| US-9,931,408 |
Bio-orthogonal drug activation The invention relates to a Prodrug activation method, for therapeutics, wherein use is made of abiotic reactive chemical groups that exhibit bio-orthogonal... |
| US-9,931,407 |
Silicon based drug conjugates and methods of using same Described herein are silicon based conjugates capable of delivering one or more payload moieties to a target cell or tissue. Contemplated conjugates may include... |
| US-9,931,406 |
Pharmaceutical composition comprising amide derivative inhibiting the
growth of cancer cells and non-metallic... Disclosed is a pharmaceutical composition comprising an amide derivative or a pharmaceutically acceptable salt thereof and a non-metallic salt lubricant, which... |
| US-9,931,405 |
Pharmaceutical compositions for gastrointestinal drug delivery A novel pharmaceutical composition, which comprises a therapeutically effective amount of active principle(s) or a pharmaceutically acceptable salt or... |
| US-9,931,404 |
Glycosaminoglycans for chemokine drug delivery A pharmaceutical composition for sustained release of a chemokine is described that includes a polymer bonded to a sulfated glycosaminoglycan and loaded with a... |
| US-9,931,403 |
Non-aqueous patch Non-aqueous patches comprising lidocaine, which is not dissolved and is present in a crystalline state, have poor permeability to the skin. Therefore,... |
| US-9,931,402 |
Compositions for the treatment of solid tumors The present invention relates to a pharmaceutical combination that comprises an IGF1R inhibitor and an mTOR inhibitor for the treatment of cancer in a subject;... |
| US-9,931,401 |
Combination comprising anti-fibroblast growth factor receptor 2 (FGFR2)
antibody and a tyrosine kinase inhibitor The present invention provides a combination of an antibody binding to a fibroblast growth factor receptor, and another agent. |
| US-9,931,400 |
Method of combination therapy for prevention or treatment of c-Met or
angiogenesis factor induced diseases Provided is a method of combination therapy for prevention or treatment of c-Met-induced or angiogenesis factor-induced diseases including co-administering an... |
| US-9,931,399 |
Adjuvanted formulations of booster vaccines The invention improves TdaP vaccines by including a TLR agonist in them. This agonist can provide stronger protection, longer-lasting protection, and/or can... |
| US-9,931,398 |
Naturally-occurring CpG oligonucleotide compositions and therapeutic
applications thereof The present invention relates to combination therapies for the treatment of a variety of disorders in mammals, including hepatic disorders and cancer. The... |
| US-9,931,397 |
Immunogenic composition The present application relates to an immunogenic composition comprising at least 2 conjugates of N. meningitidis capsular saccharide and protein carrier,... |
| US-9,931,396 |
Koi herpesvirus vaccine The present invention relates to a recombinant Koi herpesvirus (KHV), methods for the production of such KHV, cells comprising such KHV and the use of such KHV... |
| US-9,931,395 |
MVA vaccine for delivery of a UL128 complex and preventing CMV infection In one embodiment, an expression system for expressing a UL128 complex is provided herein. The expression system may include a bacterial artificial chromosome... |
| US-9,931,394 |
Soluble HIV-1 envelope glycoprotein trimers The present application relates to novel HIV-1 envelope glycoproteins which may be utilized as an HIV-1 vaccine immunogens, antigens for crystallization and for... |
| US-9,931,393 |
Immunogenic JC polyomavirus compositions and methods of use Methods of eliciting an immune response to a JC polyomavirus (JCV) by administering an effective amount of an immunogenic composition including an isolated JCV... |
| US-9,931,392 |
Glycosylation method The invention relates to microbial host cells engineered to produce glycoconjugate vaccines by stable integration of an acceptor protein and an... |
| US-9,931,391 |
Prevention and treatment of mycobacterium infection The invention relates to the identification of antigens, including Mycobacterium sulphate assimilation pathway components such as CysD, for preventing and... |
| US-9,931,390 |
Recombinant Lactococcus lactis expressing Escherichia coli colonization
factor antigen I (CFA/I) fimbriae and... The present disclosure relates generally to therapeutic compositions comprising recombinant bacteria. Further, the disclosure elaborates upon methods of... |
| US-9,931,389 |
Genetic attenuation of plasmodium by B9 gene disruption Disclosed herein are mutant Plasmodium-species parasites that are genetically attenuated (GAP). They retain the ability to infect a host and invade host... |
| US-9,931,388 |
Peptides and combination of peptides and scaffolds for use in
immunotherapy against renal cell carcinoma (RCC)... The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates... |
| US-9,931,387 |
Cancer vaccine for cats The present invention provides a nucleic acid, or an immunogenic composition thereof, that comprises a sequence encoding a cat telomerase deprived of telomerase... |
| US-9,931,386 |
Recombinant multiple domain fusion protein mitogens and use thereof for
inducing enhancement or repression of... The invention relates to cell stimulatory fusion proteins and DNA sequences, vectors comprising at least two agonists of TNF/TNFR super family, immunoglobulin... |
| US-9,931,385 |
Methods of inhibiting gonad maturation The present invention provides a method of inhibiting maturation of the gonads of a juvenile animal which comprises administering to said juvenile animal an... |
| US-9,931,384 |
Identification of CD8.sup.+ T cells that are CD161.sup.hi and/or
IL18R.alpha..sup.hi and have rapid drug efflux... This invention provides, among other things, methods for the identification and isolation of viable putative long-lived antigen-specific memory CD8.sup.+ T cell... |
| US-9,931,383 |
Treatment of mammalian physiological reaction of IgE antibodies present in
said mammal upon contact with the... A method is disclosed for blocking or reducing physiological reaction in a mammal to the interaction of IgE antibodies present in said mammal upon contact with... |
| US-9,931,382 |
Treatment of ophthalmic conditions Ophthalmic conditions such as presbyopia, myopia, and astigmatism can be corrected by the use of a molding contact lens in combination with a pharmaceutical... |
| US-9,931,381 |
Methods of comprising serratia peptidase for inhibition and treatment of
biofilms related to certain conditions Physiologically acceptable anti-biofilm compositions comprising Serratia peptidase and optionally one or more of bromelain, papain and a fibrinolytic enzyme.... |
| US-9,931,380 |
Medicament for treating olfaction disorder The object of the present invention is to provide an olfactory disturbance therapeutic agent that is effective in repairing or regenerating olfactory epithelium... |
| US-9,931,379 |
Oxyntomodulin analogs and methods of making and using same Provided are oxyntomodulin analogs. The peptide analogs have at least two cysteines. The two cysteines are separated by six amino acids such that they can be... |
| US-9,931,378 |
Method of immunotherapy for treatment of human papillomavirus infection A method of treating human papillomavirus (HPV), by administering a therapeutically effective amount of a primary cell-derived biologic to a patient infected... |
| US-9,931,377 |
Cell expressing complexes of IL-15 and IL-15Ralpha The present invention relates to agents that modulate interleukin-15 ("IL-15") signal transduction or function ("Therapeutic Agents") and the use ol'' those... |
| US-9,931,376 |
Cytokine receptor peptides, compositions thereof and methods thereof The invention provides a pharmaceutical composition including a peptide comprising at least a portion of a chemokine receptor or a G-protein coupled receptor... |
| US-9,931,375 |
Prevention of myocardial infarction induced ventricular expansion and
remodeling A method for direct therapeutic treatment of myocardial tissue in a localized region of a heart having a pathological condition. The method includes identifying... |
| US-9,931,374 |
SorCS1-like agent for use in the treatment of insulin resistance and
diseases related thereto The present invention relates to Sor CS1-like agents, including Sor CS1, nucleic acid molecule encoding expression of Sor CS1 and fragments thereof, as well as... |
| US-9,931,373 |
Method of reducing cancer cell proliferation by administering recombinant
alpha-fetoprotein Disclosed are pharmaceutical and synergistic compositions human recombinant alpha-fetoprotein expressed in eukaryotic cells for preparation of therapeutic... |
| US-9,931,372 |
Synthetic apelin fatty acid conjugates with improved half-life The invention provides a conjugate, or a pharmaceutically acceptable salt thereof, comprising a synthetic polypeptide of Formula I: ... |
| US-9,931,371 |
Angiopoietin-like 4 and a method of its use in wound healing A method and a pharmaceutical composition for increasing wound healing in an individual in need thereof, the method comprising administering an angiopoietin... |
| US-9,931,370 |
Peptide systems and methods for metabolic conditions The present invention generally relates to compositions and methods for topical or transdermal delivery, and treatment of metabolic conditions. In some cases,... |
| US-9,931,369 |
Carbohydrate-based peritoneal dialysis fluid comprising glutamine residue The present invention relates to a carbohydrate-based peritoneal dialysis fluid, containing a compound selected from the group consisting of glutamine,... |
| US-9,931,368 |
Anti-obesity and anti-dyslipidemic effects of oil palm phenolics in
treating atherosclerosis and cardiovascular... A composition comprising extracts containing oil palm phenolics in an amount effective for use in a method of reducing cholesterol biosynthesis and thus... |
| US-9,931,367 |
Uses of cistanche tubulosa extract and isoacteoside in protecting muscle Use of Cistanche tubulosa extract, isoacteoside and/or a pharmaceutical acceptable salt of isoacteoside in the manufacture of a medicament or a food product for... |
| US-9,931,365 |
Methods for treating neurological disorders using nutrient compositions Nutrient compositions comprising botanical extracts and an omega 3 fatty acid as well as methods of their use for treating, inter alia, autism or apraxia and/or... |
| US-9,931,364 |
Tube feed packages and methods for using same Nutritional compositions that mimic whole foods and methods of using the nutritional compositions are provided. The nutritional compositions may include an... |
| US-9,931,363 |
Composition comprising probiotic bacteria for use in the treatment of
immune disorders The present invention relates to a composition comprising probiotic bacteria for the treatment of pathologies associated with alterations of the immune system.... |
| US-9,931,362 |
Composition for controlling fish The present invention relates to a composition for controlling fish. In particular, the composition may be an incitant, functioning as either a fish attractant... |
File A Patent Application
- Protect your idea -- Don't let someone else file first. Learn more.
- 3 Easy Steps -- Complete Form, application Review, and File. See our process.
- Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.